Theme

Kromek Group

KMKTechnology
6.29GBX
3.11%
Market Cap
41.20M
Volume
879.44k
54% of avg
P/E Ratio
-11.44
EPS (TTM)
-0.55
Beta
0.65
Day Range
6.10p - 6.30p
52 Week Range
4.30p6.29p9.50p
6.29p

Upcoming Events

22 September 2025
Online Q&A session for investors
1 January 2026
Potential extension of Supply Agreement with Siemens Healthineers
High Impact Event
2026
Expected delivery of strong year-on-year revenue increase in CBRN Detection division
High Impact Event
Early Q2 2026
Delivery of majority of new orders
High Impact Event
30 April 2026
End of current financial year
2027
Anticipated full maturity of biological-threat detection technology
High Impact Event
KMK
GOOD

Kromek Group Reports First-Ever Profit, Exceeding Market Expectations

This radiation and bio-detection technology developer reported its first-ever profit, significantly exceeding market expectations. Revenue surged 37%, driven by a landmark agreement with Siemens Healthineers.

KMK
GOOD

Kromek Secures New Biosecurity Contract from UK MoD

The technology company has secured a new biosecurity contract from the UK Ministry of Defence and received additional CBRN detection orders from global customers, providing increased visibility on future revenue.

KMK
GOOD

Kromek Receives $5m Under Siemens Healthineers Agreement

The technology company has received a $5m payment under its agreement with a major healthcare partner, strengthening its balance sheet and providing a foundation for sustainable growth.

KMK
GOOD

Kromek Wins £1.7m Contract Under UK Government Framework

The technology company has secured a £1.7m contract under the UK Government's Radiological Nuclear Detection Framework, affirming its leadership in the CBRN detection sector.

KMK
NEUTRAL

Kromek Hosts Capital Markets Day Presentation

The technology company hosts a presentation for investors, providing an overview of its business and operations.

KMK
NEUTRAL

Kromek Hosts Capital Markets Day to Outline Growth Strategy

The scientific instruments company is hosting a capital markets day to discuss its growth strategy, including plans to scale the business to achieve revenues over £60m and a 30% EBITDA margin.

KMK
NEUTRAL

Kromek Group Announces Holding Change

The technology company has announced a change in shareholding, with Polymer N2 Limited increasing its stake to 15.28%.

KMK
GOOD

Kromek Group Raises Funds to Repay Loan Facility

The technology company has issued new shares to satisfy the payment of accrued interest on a loan facility, improving its financial position.

KMK
NEUTRAL

Kromek Group Announces Director's Dealings

The technology company has announced a change in major shareholding by a significant investor.

KMK
NEUTRAL

Kromek Group Announces Capital Markets Day

The scientific instruments company is hosting a capital markets day for investors and analysts to discuss its strategy and growth prospects.